These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7436556)

  • 21. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis.
    Hakoda M; Taniguchi A; Kamatani N; Akahoshi T; Kashiwazaki S
    J Rheumatol; 1994 Sep; 21(9):1637-41. PubMed ID: 7799341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study.
    van Rijthoven AW; Dijkmans BA; Thè HS; Meijers KA; Montnor-Beckers ZL; Moolenburgh JD; Boers M; Cats A
    J Rheumatol; 1991 Jun; 18(6):815-20. PubMed ID: 1895262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial.
    Berry H; Liyanage SP; Durance RA; Barnes CG; Berger LA; Evans S
    Br Med J; 1976 May; 1(6017):1052-4. PubMed ID: 773500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative evaluation of the effectiveness of gold preparations and D-penicillamine and their tolerance in rheumatoid arthritis. I. The effect on the indicators of their activity and tolerance].
    Slobodina GA; Kanevskaia MZ; Krel' AA; Chichasova NV
    Revmatologiia (Mosk); 1989; (1):8-16. PubMed ID: 2501852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled multicenter trial of tiopronin and d-penicillamine for rheumatoid arthritis.
    Pasero G; Pellegrini P; Ambanelli U; Ciompi ML; Colamussi V; Ferraccioli G; Barbieri P; Mazzoni MR; Menegale G; Trippi D
    Arthritis Rheum; 1982 Aug; 25(8):923-9. PubMed ID: 7115451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation single fiber EMG study in patients receiving a long-term D-penicillamine treatment for rheumatoid arthritis.
    Dominkus M; Grisold W; Albrecht G
    Muscle Nerve; 1992 Nov; 15(11):1300-1. PubMed ID: 1488070
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of penicillamine on the laboratory parameters in rheumatoid arthritis.
    Jaffe IA
    Arthritis Rheum; 1965 Dec; 8(6):1064-79. PubMed ID: 5884817
    [No Abstract]   [Full Text] [Related]  

  • 28. Dose, plasma concentration and response relationships of D-penicillamine in patients with rheumatoid arthritis.
    Brooks PM; Miners JO; Smith K; Smith MD; Fearnley I; Birkett DJ
    J Rheumatol; 1984 Dec; 11(6):772-5. PubMed ID: 6520830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of alclofenac treatment on acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
    Maddock J; Rees P; Holly F; Aylward M
    Curr Med Res Opin; 1975; 3(5):286-97. PubMed ID: 241598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination D-penicillamine and methotrexate therapy: proposal for early and aggressive treatment for rheumatoid arthritis.
    Lee S; Solomon G
    Bull Hosp Jt Dis Orthop Inst; 1990; 50(2):160-8. PubMed ID: 2175662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enteric-coated aspirin in rheumatoid arthritis.
    Bird HA; Rhind V; Leatham P; Saunders A; Wright V
    Rheumatol Rehabil; 1981 May; 20(2):116-21. PubMed ID: 6792691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis.
    Kean WF; Dwosh IL; Anastassiades TP; Ford PM; Kelly HG
    Arthritis Rheum; 1980 Feb; 23(2):158-64. PubMed ID: 7362666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-penicillamine in patients with rheumatoid arthritis. Serum levels, pharmacokinetic aspects, and correlation with clinical course and side effects.
    Muijsers AO; van de Stadt RJ; Henrichs AM; Ament HJ; van der Korst JK
    Arthritis Rheum; 1984 Dec; 27(12):1362-9. PubMed ID: 6508861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of D-penicillamine on lymphocyte subsets: correlation with clinical response in rheumatoid arthritis.
    Singh RR; Malaviya AN; Malaviya R; Sharma M; Shandilya R; Taneja V; Khare SD; Beri D; Kumar A; Mehra NK
    J Assoc Physicians India; 1994 Mar; 42(3):201-4. PubMed ID: 7860508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [D-penicillamine in the treatment of rheumatoid polyarthritis. 104 cases with a 5-year follow-up].
    Valat JP; Fouquet B; Eveleigh MC; Chantreuil C; Lalot F
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):7-12. PubMed ID: 3704516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [D-penicillamine (Artamin) as basic therapeutic agent in the treatment of chronic rheumatoid arthritis].
    Tausch G; Bröll H; Eberl R
    Wien Klin Wochenschr; 1973 Jan; 85(4):59-63. PubMed ID: 4567434
    [No Abstract]   [Full Text] [Related]  

  • 37. D-penicillamine-induced polymyositis in patients with rheumatoid arthritis.
    Takahashi K; Ogita T; Okudaira H; Yoshinoya S; Yoshizawa H; Miyamoto T
    Arthritis Rheum; 1986 Apr; 29(4):560-4. PubMed ID: 3707633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The long term treatment of rheumatoid arthritis with D-penicillamine].
    Krüger HH
    Verh Dtsch Ges Rheumatol; 1969; 1():387-94. PubMed ID: 4997350
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.
    Dixon AJ; Davies J; Dormandy TL; Hamilton EB; Holt PJ; Mason RM; Thompson M; Weber JC; Zutshi DW
    Ann Rheum Dis; 1975 Oct; 34(5):416-21. PubMed ID: 769707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multicentric ambulatory trial of Trolovol (D-penicillamine) in chronic polyarthritis].
    Tautz VI
    Z Rheumatol; 1975; 34(3-4):87-93. PubMed ID: 806188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.